Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin vs Amoxicillin/Clavulanate in Acute Bacterial Rhinosinusitis
NCT00493038Phase 4Terminated
- Sponsor
- Bayer
- Start
- Feb 2006
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of moxifloxacin in Acute bacterial rhinosinusitis (ABRS) (2 arms), sponsored by Bayer. Primary endpoint: Number of Participants With Response (Per-protocol Population). Started Feb 2006; status: terminated.
02
Drugs
moxifloxacin
03
Conditions
Acute bacterial rhinosinusitis (ABRS)
Beyond the preview
Go deeper on NCT00493038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493038.